Jul 17, 2026 08:00AM
Jul 17, 2026 08:00AM
Jun 29, 2026 04:29PM
Jun 29, 2026 04:20PM
Jun 29, 2026 03:00AM
Jun 29, 2026 03:00AM
Jun 5, 2026 08:00AM Amneal reports positive interim results for Parkinson's drug CREXONT
Jun 5, 2026 08:00AM
Jun 5, 2026 08:00AM
Jun 5, 2026 08:00AM
Jun 4, 2026 08:00AM
Jun 4, 2026 08:00AM
May 7, 2026 04:01PM
Apr 22, 2026 06:00AM Amneal agrees to acquire Kashiv BioSciences for $750 million
Apr 22, 2026 06:00AM
Apr 20, 2026 08:02AM
Apr 20, 2026 08:00AM
Apr 14, 2026 08:00AM
Apr 7, 2026 08:00AM
Apr 7, 2026 08:00AM
Mar 9, 2026 10:53AM FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'
Dec 23, 2025 01:29PM
Dec 22, 2025 04:01PM
Dec 22, 2025 04:01PM
Dec 22, 2025 04:01PM
Dec 9, 2025 04:01PM
Dec 9, 2025 04:01PM
Dec 5, 2025 08:02AM Amneal reports positive interim results for Parkinson's drug CREXONT
Dec 5, 2025 08:00AM
Dec 2, 2025 08:00AM
Dec 2, 2025 08:00AM
Dec 1, 2025 04:01PM
Dec 1, 2025 04:01PM
Nov 13, 2025 04:01PM
Nov 13, 2025 04:01PM Amneal Receives U.S. FDA Approval for Iohexol Injection
Oct 30, 2025 06:00AM
Oct 29, 2025 04:09PM
Oct 29, 2025 04:05PM
Oct 27, 2025 08:00AM
Oct 6, 2025 08:00AM
Sep 26, 2025 08:02AM
Sep 26, 2025 08:00AM Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
Sep 23, 2025 08:00AM
Sep 23, 2025 08:00AM
Sep 11, 2025 08:00AM
Sep 11, 2025 08:00AM
Sep 4, 2025 04:01PM
Sep 4, 2025 04:01PM
Aug 5, 2025 06:00AM Amneal Reports Second Quarter 2025 Financial Results
Jul 21, 2025 07:40AM

325,890 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All